1
|
Millet C, Ducret M, Lafon A. Prosthetic Management of Albers-Schönberg Disease with Osteomyelitis: A 10-Year Follow-up Case Report. INT J PROSTHODONT 2023; 36:642-648. [PMID: 36484669 DOI: 10.11607/ijp.8255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2023]
Abstract
Albers-Schönberg disease is a rare bone syndrome characterized by increased bone density and infectious complications after dental extraction or minor surgery. The prosthodontic management of such edentulous patients with osteomyelitis is very challenging and requires special strategies due to a high risk of failure and worsening of the condition. This clinical report describes the rehabilitation of a 31-year-old edentulous woman presenting with Albers-Schönberg disease, secondary chronic osteomyelitis, maxillary hypoplasia, compromised oral conditions, temporomandibular disorders, and psychologic distress. The treatment included a mandibulectomy and removable prostheses. A crucial element for the successful long-term treatment and quality of life improvement observed in this patient was the 1-year transitional phase with interim dentures and frequent follow-up appointments. The complications and management proposed during a 10-year follow-up are presented. Int J Prosthodont 2023;36:642-648.
Collapse
|
2
|
Millet C, Duprez JP, Tra BZR, Morgon L, Lafon A. Interdisciplinary rehabilitation using CAD-CAM technology for a young patient with severe malocclusion and amelogenesis imperfecta: A 5-year follow-up case report. INT J PROSTHODONT 2023; 0:4500179. [PMID: 37824124 DOI: 10.11607/ijp.8656] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/13/2023]
Abstract
Treatment of acute cases of amelogenesis imperfecta is challenging in children due to the absence of a consensus statement on therapy recommendations. This article presents the effectiveness of an interdisciplinary approach, including orthodontics, orthognathic surgery, and prosthodontics using digital technology, in a child with amelogenesis imperfecta and skeletal deformities. The early management over a 6-year period had a very positive impact on the quality of life related to oral health. The full-mouth rehabilitation in adulthood with all-ceramic crowns showed a fully satisfactory result after 60 months of follow-up.
Collapse
|
3
|
Attik N, Phantarasmy M, Abouelleil H, Chevalier C, Barraco A, Grosgogeat B, Lafon A. Comparison of the Biological Behavior and Topographical Surface Assessment of a Minimally Invasive Dental Implant and a Standard Implant: An In Vitro Study. Materials (Basel) 2022; 15:ma15217540. [PMID: 36363140 PMCID: PMC9655689 DOI: 10.3390/ma15217540] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/26/2022] [Revised: 10/03/2022] [Accepted: 10/20/2022] [Indexed: 05/31/2023]
Abstract
The current study aimed to assess the topographical and physical properties of a minimally invasive implant (MagiCore®: MC®, InnosBioSurg, IBS) and to evaluate its biological behavior compared to a gold standard implant (NobelParallel™: NB™, Nobel Biocare™). After surface characterization, the biological behavior assessment was conducted regarding human gingival fibroblasts (hGF) and osteoblast-like cells (MG63). Roughness values for NBTM were Ra = 1.28 µm and for MC® they were Ra = 2.02 µm. Alamar BlueTM assay LIVE/DEADTM staining results indicated equivalent biological development regarding both cell types for the two implants. Significant enhancement was found for hGF ALP activity in the presence of the two tested implants in a time-dependent manner from day 7 to day 14 (** p < 0.01). Alizarin red staining demonstrated significant calcium deposition enhancement when cells were interfaced with the NB™ compared to the MC® implant (** p < 0.05). Moreover, SEM and confocal imaging revealed good cell adhesion with a denser cellular layer on the MC® than the NB™ surface. The MC® cytocompatibility was ranked as equivalent to the gold standard implant despite the surface properties differences. These findings provide new insights about the minimally invasive implant’s biological behavior and its potential clinical implication in different implantology situations.
Collapse
Affiliation(s)
- Nina Attik
- Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne, France
- Faculté d’Odontologie, Université Claude Bernard Lyon 1, Université de Lyon, 69372 Lyon, France
| | - Marina Phantarasmy
- Faculté d’Odontologie, Université Claude Bernard Lyon 1, Université de Lyon, 69372 Lyon, France
| | - Hazem Abouelleil
- Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne, France
- Faculté d’Odontologie, Université Claude Bernard Lyon 1, Université de Lyon, 69372 Lyon, France
| | - Charlène Chevalier
- Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne, France
| | - Aurore Barraco
- Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne, France
- Hospices Civils de Lyon, Service d’Odontologie, 69003 Lyon, France
| | - Brigitte Grosgogeat
- Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne, France
- Faculté d’Odontologie, Université Claude Bernard Lyon 1, Université de Lyon, 69372 Lyon, France
- Hospices Civils de Lyon, Service d’Odontologie, 69003 Lyon, France
| | - Arnaud Lafon
- Laboratoire des Multimatériaux et Interfaces, UMR CNRS 5615, Université Claude Bernard Lyon 1, Université de Lyon, 69622 Villeurbanne, France
- Faculté d’Odontologie, Université Claude Bernard Lyon 1, Université de Lyon, 69372 Lyon, France
- Hospices Civils de Lyon, Service d’Odontologie, 69003 Lyon, France
| |
Collapse
|
4
|
Ligerot R, Lenganey H, Bodard AGC, Laforest L, Lafon A. Surgical transpose of an impacted maxillary canine with bone flap replacement. J Oral Med Oral Surg 2022. [DOI: 10.1051/mbcb/2022006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Introduction: Management of an edentulous area when the tooth is impacted is often a challenge. Usually, treatments are by far orthodontic traction followed by tooth removal with dental implant placement. With piezosurgery, minimally invasive auto-transplantation can be an alternative. Observation: A 27-year-old patient presenting terminal mobility of the tooth no°63 consulted for replacement. Among the different therapeutic solutions, a surgical transposition of her impacted tooth no°23 with a conservative bone window replacement was decided. After a 12-month follow up period, X-rays showed no sign of ankylosis, root resorption or apical pathology, while clinical criteria such as tooth function, mobility and aesthetic integration were all satisfying. Commentaries: Space closure, dental implant and bonded bridge were alternatives. The interest of this clinical case is to restore the functional and aesthetic roles of the canine without compromising any potential implant placement later. Also the patient can still have the possibility to opt for an implant-supported crown in the long-term thanks to the bone volume maintained. Conclusion: When orthodontic realignment is considered as not possible, auto-transplantation of a tooth can be a good choice before going on dental implant therapeutic.
Collapse
|
5
|
Chacun D, Lafon A, Courtois N, Reveron H, Chevalier J, Margossian P, Alves A, Gritsch K, Grosgogeat B. Histologic and histomorphometric evaluation of new zirconia-based ceramic dental implants: A preclinical study in dogs. Dent Mater 2021; 37:1377-1389. [PMID: 34238605 DOI: 10.1016/j.dental.2021.06.010] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Revised: 06/12/2021] [Accepted: 06/17/2021] [Indexed: 11/18/2022]
Abstract
OBJECTIVE Healing of soft tissues and improvement of aesthetics have become major research objectives in implantology and renewed the interest for ceramics implants. The aim of this study was to evaluate the pre-clinical performance of screw-shaped sandblasted-etched implants processed from an innovative zirconia-based ceramic composite, in comparison to titanium. METHODS Twenty-four ceramic and twenty-four titanium screw-shaped sandblasted-etched dental implants were tested in a split-mouth design in six Beagle dogs. Surface topographies were investigated by confocal microscopy. Local tissue effects were evaluated at 4 and 13 weeks after implantation through histology. An ANOVA statistical analysis (5% risk; p < 0.05) was performed to compare peri-implant quantitative histomorphometric parameters on buccal and lingual sides, including Bone to Implant Contact (BIC) among test groups and time-periods. RESULTS Titanium and ceramic implants presented respectively moderate and minimal roughness. After 4 and 13 weeks, ceramic implants showed an inflammatory tissue response close to titanium implants. At both period of time there was no significant difference between the titanium and ceramic groups in terms of BIC values (mean ± SD) at the lingual or buccal sides or when combining buccal + lingual BIC values (respectively for titanium and ceramic, 68.4 ± 14.7 % and 75.0 ± 13.5 % at 4 weeks, and 92.0 ± 8.6 % and 86.1 ± 13.8 % at 13 weeks). SIGNIFICANCE Within the limits of the present study, it can be concluded that newly developed zirconia-based ceramic composite dental implants have similar biocompatibility and osseointegration to those observed in titanium implants. These pre-clinical results corroborate the potential for the use of these new zirconia-based ceramics in oral implantology.
Collapse
Affiliation(s)
- Doriane Chacun
- Université de Lyon, Lyon, Université Lyon 1, Laboratoire des Multimatériaux et Interfaces UMR CNRS 5615, Faculté d'Odontologie, 69372 Lyon Cedex 08, France; Hospices Civils de Lyon, Pôle d'Odontologie, Lyon, France
| | - Arnaud Lafon
- Université de Lyon, Lyon, Université Lyon 1, Laboratoire des Multimatériaux et Interfaces UMR CNRS 5615, Faculté d'Odontologie, 69372 Lyon Cedex 08, France; Hospices Civils de Lyon, Pôle d'Odontologie, Lyon, France
| | | | - Helen Reveron
- Université de Lyon, INSA-Lyon, MATEIS UMR CNRS 5510, 69621 Villeurbanne Cedex, France
| | - Jérôme Chevalier
- Université de Lyon, INSA-Lyon, MATEIS UMR CNRS 5510, 69621 Villeurbanne Cedex, France
| | - Patrice Margossian
- Exclusive Private Practice of Implantology and Periodontology, Marseille, France
| | | | - Kerstin Gritsch
- Université de Lyon, Lyon, Université Lyon 1, Laboratoire des Multimatériaux et Interfaces UMR CNRS 5615, Faculté d'Odontologie, 69372 Lyon Cedex 08, France; Hospices Civils de Lyon, Pôle d'Odontologie, Lyon, France
| | - Brigitte Grosgogeat
- Université de Lyon, Lyon, Université Lyon 1, Laboratoire des Multimatériaux et Interfaces UMR CNRS 5615, Faculté d'Odontologie, 69372 Lyon Cedex 08, France; Hospices Civils de Lyon, Pôle d'Odontologie, Lyon, France.
| |
Collapse
|
6
|
Lafon A, Faivre L, Seux D, Gautier E, Duplomb L, Grogogeat B, Marcelet A, Laforest L. Periodontal disorders in a cohort of patients with Cohen syndrome. Spec Care Dentist 2020; 41:118-124. [PMID: 33202072 DOI: 10.1111/scd.12544] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2020] [Revised: 10/01/2020] [Accepted: 10/24/2020] [Indexed: 11/27/2022]
Abstract
AIMS Cohen syndrome (CS) is an uncommon autosomal recessive disorder due to mutations in vacuolar protein sorting 13B, with an intermittent presence of neutropenia. Contrary to other clinical phenotypic features, oral health has been little investigated in CS. We described oral health and dental hygiene in a cohort of CS patients. METHODS AND RESULTS Twelve CS patients with neutropenia (<1500/mm3 ) were recruited in the dental department of Dijon University Hospital (France). Patients underwent oral examination, and blood samples were collected. Oral health markers were described and compared between patients with moderate and severe neutropenia (<500/mm3 ). In 12 patients (mean age = 21.1 years, SD = 13.7, six females), 45.5% brushed at least twice daily their teeth, and the same percentage annually visited a dentist. Dental plaque index was high (mean = 1.7, SD = 1.4). So was the number of lost teeth per patient, notably among adults (mean = 13.8, SD = 9.8). Elevated markers of periodontitis were noted as percentage of bleeding dental sites (mean = 70.2%, SD = 45.2%) or Gingival Index (mean = 2.2, SD = 1.0). The severity of neutropenia was correlated to the level of tooth-loss (P = .03). CONCLUSION This study highlighted in CS patients worrisome oral health and dental follow-up in the context of intellectual disability with behavioural anomalies. More attention is needed by care-givers on oral condition in CS.
Collapse
Affiliation(s)
- Arnaud Lafon
- Faculté d'odontologie, Université de Lyon, Université Lyon 1, Lyon, France.,Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Lyon, France.,Enseignant chercheur du Laboratoire Parcours de Santé Systémique EA 4129-Ecole Doctorale EDISS, Université Claude Bernard Lyon 1, Lyon, France
| | - Laurence Faivre
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, Dijon, France.,FHU TRANSLAD, Département de Génétique, CHU Dijon, Université de Bourgogne Franche-Comté, Dijon, France.,Centre de référence Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants, CHU Dijon, Dijon, France
| | - Dominique Seux
- Faculté d'odontologie, Université de Lyon, Université Lyon 1, Lyon, France.,Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Lyon, France.,Université de Lyon, LMI UMR CNRS 5615, Lyon, France
| | - Elodie Gautier
- FHU TRANSLAD, Département de Génétique, CHU Dijon, Université de Bourgogne Franche-Comté, Dijon, France.,Centre de référence Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants, CHU Dijon, Dijon, France
| | - Laurence Duplomb
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, Dijon, France.,FHU TRANSLAD, Département de Génétique, CHU Dijon, Université de Bourgogne Franche-Comté, Dijon, France
| | - Brigitte Grogogeat
- Faculté d'odontologie, Université de Lyon, Université Lyon 1, Lyon, France.,Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Lyon, France.,Université de Lyon, LMI UMR CNRS 5615, Lyon, France
| | | | - Laurent Laforest
- Faculté d'odontologie, Université de Lyon, Université Lyon 1, Lyon, France
| |
Collapse
|
7
|
Chacun D, Lafon A, Courtois N, Margossian P, Gritsch K, Grosgogeat B. Compared osseointegration of a novel zirconia material and titanium on blasted implants in dogs. Clin Oral Implants Res 2020. [DOI: 10.1111/clr.10_13643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
8
|
Vabres P, Sorlin A, Kholmanskikh SS, Demeer B, St-Onge J, Duffourd Y, Kuentz P, Courcet JB, Carmignac V, Garret P, Bessis D, Boute O, Bron A, Captier G, Carmi E, Devauchelle B, Geneviève D, Gondry-Jouet C, Guibaud L, Lafon A, Mathieu-Dramard M, Thevenon J, Dobyns WB, Bernard G, Polubothu S, Faravelli F, Kinsler VA, Thauvin C, Faivre L, Ross ME, Rivière JB. Author Correction: Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome. Nat Genet 2019; 51:1660. [PMID: 31611689 DOI: 10.1038/s41588-019-0527-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Collapse
Affiliation(s)
- Pierre Vabres
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France. .,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France. .,Centre de Référence MAGEC, Service de Dermatologie, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.
| | - Arthur Sorlin
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Centre de Référence MAGEC, Service de Dermatologie, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,Service de Pédiatrie 1 et de Génétique Médicale, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - Stanislav S Kholmanskikh
- Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA
| | - Bénédicte Demeer
- Unité de Génétique Médicale et Oncogénétique, Centre Hospitalier Universitaire Amiens Picardie, Amiens, France
| | - Judith St-Onge
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
| | - Yannis Duffourd
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France
| | - Paul Kuentz
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Génétique Biologique Histologie, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
| | - Jean-Benoît Courcet
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Service de Pédiatrie 1 et de Génétique Médicale, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - Virginie Carmignac
- UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Centre de Référence MAGEC, Service de Dermatologie, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - Philippine Garret
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France
| | - Didier Bessis
- Département de Dermatologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
| | - Odile Boute
- Service de Génétique Clinique, Centre Hospitalier Universitaire Lille, Lille, France
| | - Alain Bron
- Service d'Ophtalmologie, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - Guillaume Captier
- Service de Chirurgie Orthopédique et plastique Pédiatrique, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
| | | | - Bernard Devauchelle
- Département de Chirurgie Maxillo-Faciale et Stomatologie, Centre Hospitalier Universitaire Amiens Picardie, Amiens, France
| | - David Geneviève
- Département de Génétique Médicale, Maladies rares et Médecine Personnalisée, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
| | - Catherine Gondry-Jouet
- Départment de Radiologie, Centre Hospitalier Universitaire Amiens Picardie, Amiens, France
| | - Laurent Guibaud
- Service d'Imagerie Pédiatrique et Foetale, Hôpital Femme-Mère-Enfant Louis Pradel, Hospices Civils de Lyon, Bron, France
| | - Arnaud Lafon
- Service d'Odontologie-Stomatologie, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - Michèle Mathieu-Dramard
- Unité de Génétique Médicale et Oncogénétique, Centre Hospitalier Universitaire Amiens Picardie, Amiens, France
| | - Julien Thevenon
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Service de Pédiatrie 1 et de Génétique Médicale, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - William B Dobyns
- Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA
| | - Geneviève Bernard
- Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.,Departments of Neurology and Neurosurgery, and Pediatrics McGill University, Montreal, Quebec, Canada.,Department of Medical Genetics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada
| | | | | | | | - Christel Thauvin
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Service de Pédiatrie 1 et de Génétique Médicale, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - Laurence Faivre
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France.,Service de Pédiatrie 1 et de Génétique Médicale, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
| | - M Elizabeth Ross
- Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA
| | - Jean-Baptiste Rivière
- Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France. .,UMR Inserm 1231 Génétique des Anomalies du Développement, Université Bourgogne Franche-Comté, Dijon, France. .,Child Health and Human Development Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. .,Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
| |
Collapse
|
9
|
Duplomb L, Rivière J, Jego G, Da Costa R, Hammann A, Racine J, Schmitt A, Droin N, Capron C, Gougerot-Pocidalo MA, Dubrez L, Aral B, Lafon A, Edery P, Ghoumid J, Blair E, El Chehadeh-Djebbar S, Carmignac V, Thevenon J, Guy J, Girodon F, Bastie JN, Delva L, Faivre L, Thauvin-Robinet C, Solary E. Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropenia. J Mol Med (Berl) 2019; 97:633-645. [PMID: 30843084 DOI: 10.1007/s00109-019-01754-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2018] [Revised: 01/16/2019] [Accepted: 02/01/2019] [Indexed: 12/16/2022]
Abstract
Cohen syndrome (CS) is a rare genetic disorder due to mutations in VPS13B gene. Among various clinical and biological features, CS patients suffer from inconsistent neutropenia, which is associated with recurrent but minor infections. We demonstrate here that this neutropenia results from an exaggerate rate of neutrophil apoptosis. Besides this increased cell death, which occurs in the absence of any endoplasmic reticulum stress or defect in neutrophil elastase (ELANE) expression or localization, all neutrophil functions appeared to be normal. We showed a disorganization of the Golgi apparatus in CS neutrophils precursors, that correlates with an altered glycosylation of ICAM-1 in these cells, as evidenced by a migration shift of the protein. Furthermore, a striking decrease in the expression of SERPINB1 gene, which encodes a critical component of neutrophil survival, was detected in CS neutrophils. These abnormalities may account for the excessive apoptosis of neutrophils leading to neutropenia in CS. KEY MESSAGES: Cohen syndrome patients' neutrophils display normal morphology and functions. Cohen syndrome patients' neutrophils have an increased rate of spontaneous apoptosis compared to healthy donors' neutrophils. No ER stress or defective ELA2 expression or glycosylation was observed in Cohen syndrome patients' neutrophils. SerpinB1 expression is significantly decreased in Cohen syndrome neutrophils as well as in VPS13B-deficient cells.
Collapse
Affiliation(s)
- Laurence Duplomb
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.
| | - Julie Rivière
- Inserm UMR1170, Gustave Roussy Cancer Center, F-94800, Villejuif, France
| | - Gaëtan Jego
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Romain Da Costa
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Arlette Hammann
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Jessica Racine
- Laboratoire d'hématologie, CHU Dijon, F-21000, Dijon, France
| | - Alain Schmitt
- Inserm, U1016, Institut Cochin, F-75679, Paris, France.,Cnrs, UMR8104, F-75674, Paris, France.,Sorbonne Paris Cité, Université Paris Descartes, F-75000, Paris, France
| | - Nathalie Droin
- Inserm UMR1170, Gustave Roussy Cancer Center, F-94800, Villejuif, France
| | - Claude Capron
- Inserm, U1016, Institut Cochin, F-75679, Paris, France.,Cnrs, UMR8104, F-75674, Paris, France.,Sorbonne Paris Cité, Université Paris Descartes, F-75000, Paris, France
| | - Marie-Anne Gougerot-Pocidalo
- Inserm U1149-Centre de Recherche sur l'Inflammation, Université Paris Diderot, F-75890, Paris, France.,Unité Dysfonctionnement Immunitaire, CHU Xavier Bichat, F-75877, Paris, France
| | - Laurence Dubrez
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Bernard Aral
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Arnaud Lafon
- Laboratoire d'odontologie, CHU Dijon, F-21000, Dijon, France
| | - Patrick Edery
- Service de génétique clinique, Hôpital Femme Mère Enfant, CHU Lyon, HCL, F-69000, Lyon, France
| | - Jamal Ghoumid
- Centre de Référence Maladies Rares Anomalies du Développement et Syndromes Malformatifs Nord, Hôpital Jeanne de Flandres, CHRU Lille, F-59037, Lille, France
| | - Edward Blair
- Department of Clinical Genetics, Oxford Regional Genetics Service, The Churchill Hospital, Oxford, OX3 9DU, UK
| | | | - Virginie Carmignac
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Julien Thevenon
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Julien Guy
- Laboratoire d'hématologie, CHU Dijon, F-21000, Dijon, France
| | | | - Jean-Noël Bastie
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.,Laboratoire d'hématologie, CHU Dijon, F-21000, Dijon, France
| | - Laurent Delva
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France
| | - Laurence Faivre
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.,FHU TRANSLAD, Département de Génétique, CHU Dijon, Université de Bourgogne Franche-Comté, F-21000, Dijon, France.,Centre de référence Anomalies du Développement et Syndromes Malformatifs, Hôpital d'Enfants, CHU Dijon, F-21000, Dijon, France
| | - Christel Thauvin-Robinet
- Inserm UMR1231, Team Génétique des Anomalies du Développement, Université de Bourgogne Franche Comté, 15 bd Maréchal de Lattre de Tassigny, 21089, F-21000, Dijon, France.,FHU TRANSLAD, Département de Génétique, CHU Dijon, Université de Bourgogne Franche-Comté, F-21000, Dijon, France.,Centre de référence Déficience Intellectuelle, Hôpital d'Enfants, CHU Dijon, F-21000, Dijon, France
| | - Eric Solary
- Inserm UMR1170, Gustave Roussy Cancer Center, F-94800, Villejuif, France
| |
Collapse
|
10
|
Abstract
OBJECTIVE This study aimed to investigate the association between clinical and radiological markers of periodontal disease and ischemic stroke and to assess the potential influence of inflammatory response on the observed associations. METHODS A prospective case-control study including a series of 48 cases with a minor ischemic stroke and 47 controls was conducted at the University Hospital of Dijon. Vascular risk factors, clinical dental examination (plaque index, gingival index, percentage of pockets >5 mm, percentage of bleeding on probing (BOP) sites), dental panoramic (bone loss) and biological parameters (CRP, total cholesterol, HDL, LDL, fasting glucose) were collected. Conditional regression analyses were performed to identify factors associated with ischemic stroke. RESULTS The prevalence of hypertension, high CRP and glucose levels and overall odontological variables was higher in stroke patients. In multivariable analyses, hypertension (OR = 12.56; 95% CI = 2.29-69.96, p = 0.004), CRP levels >5 mg/L (OR = 18.54; 95% CI = 2.01-171.17, p = 0.010), BOP (OR = 1.049; 95% CI = 1.012-1.88, p = 0.009) and bone loss >20% (OR = 1.053; 95% CI = 1.017-1.091, p = 0.004) were associated with ischemic stroke. Among stroke patients, there was a non-significant trend towards higher CRP levels in patients with bone loss >20% compared with those with bone loss <20% (8.1 ± 1.27 mg/L vs 3.12 ± 3.14 mg/L, p = 0.25), whereas other biological parameters were very similar between the two groups. CONCLUSION This case-control study demonstrates that periodontal disease, especially markers such as BOP and bone loss, is independently associated with ischemic stroke.
Collapse
Affiliation(s)
- Arnaud Lafon
- University of Champagne-Ardenne , Reims Cedex , France
| | | | | | | | | | | |
Collapse
|
11
|
Thevenon J, Milh M, Feillet F, St-Onge J, Duffourd Y, Jugé C, Roubertie A, Héron D, Mignot C, Raffo E, Isidor B, Wahlen S, Sanlaville D, Villeneuve N, Darmency-Stamboul V, Toutain A, Lefebvre M, Chouchane M, Huet F, Lafon A, de Saint Martin A, Lesca G, El Chehadeh S, Thauvin-Robinet C, Masurel-Paulet A, Odent S, Villard L, Philippe C, Faivre L, Rivière JB. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. Am J Hum Genet 2014; 95:113-20. [PMID: 24995870 DOI: 10.1016/j.ajhg.2014.06.006] [Citation(s) in RCA: 100] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2014] [Accepted: 06/11/2014] [Indexed: 01/01/2023] Open
Abstract
Epileptic encephalopathy (EE) refers to a clinically and genetically heterogeneous group of severe disorders characterized by seizures, abnormal interictal electro-encephalogram, psychomotor delay, and/or cognitive deterioration. We ascertained two multiplex families (including one consanguineous family) consistent with an autosomal-recessive inheritance pattern of EE. All seven affected individuals developed subclinical seizures as early as the first day of life, severe epileptic disease, and profound developmental delay with no facial dysmorphism. Given the similarity in clinical presentation in the two families, we hypothesized that the observed phenotype was due to mutations in the same gene, and we performed exome sequencing in three affected individuals. Analysis of rare variants in genes consistent with an autosomal-recessive mode of inheritance led to identification of mutations in SLC13A5, which encodes the cytoplasmic sodium-dependent citrate carrier, notably expressed in neurons. Disease association was confirmed by cosegregation analysis in additional family members. Screening of 68 additional unrelated individuals with early-onset epileptic encephalopathy for SLC13A5 mutations led to identification of one additional subject with compound heterozygous mutations of SLC13A5 and a similar clinical presentation as the index subjects. Mutations affected key residues for sodium binding, which is critical for citrate transport. These findings underline the value of careful clinical characterization for genetic investigations in highly heterogeneous conditions such as EE and further highlight the role of citrate metabolism in epilepsy.
Collapse
|
12
|
Lafon A, Pereira B, Dufour T, Rigouby V, Giroud M, Béjot Y, Tubert-Jeannin S. Periodontal disease and stroke: a meta-analysis of cohort studies. Eur J Neurol 2014; 21:1155-61, e66-7. [PMID: 24712659 DOI: 10.1111/ene.12415] [Citation(s) in RCA: 113] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2013] [Accepted: 02/10/2014] [Indexed: 12/31/2022]
Abstract
This review aimed to determine the association between periodontal disease and stroke incidence by a meta-analysis of cohort studies. Cohort studies that evaluated the incidence of stroke (fatal or non-fatal, ischaemic or haemorrhagic) and baseline periodontal status and calculated relative risk values were included. The quality of the included studies was assessed using an evaluation grid. The analyses were conducted separately for three outcomes: periodontitis, gingivitis and loss of teeth. Adjusted values of relative risk or of hazard ratio were used to assess risk values in each study. Random effects meta-analyses were conducted when data could be pooled. From the 743 references retrieved, only nine cohort studies were suitable for inclusion in this review. Quality scores of the studies varied greatly. Three prospective studies, which used reliable indicators of periodontal disease, obtained the highest scores. Conversely, three studies that used a subjective evaluation of stroke incidence or diagnosed stroke without imaging obtained the lowest score. The results of the meta-analyses varied depending on the outcome considered and the type of stroke. The risk of stroke was significantly increased by the presence of periodontitis [relative risk 1.63 (1.25, 2.00)]. Tooth loss was also a risk factor for stroke [relative risk 1.39 (1.13, 1.65)]. The risk of stroke did not vary significantly with the presence of gingivitis. This review shows that periodontitis and tooth loss are associated with the occurrence of stroke.
Collapse
Affiliation(s)
- A Lafon
- CHU Dijon, Service Odontologie, Hôpital Général, Dijon, France; Dental Faculty of Reims, University of Champagne-Ardenne, Dijon, France
| | | | | | | | | | | | | |
Collapse
|
13
|
Salameh C, Canoui-Poitrine F, Cortet M, Lafon A, Rudigoz RC, Huissoud C. [Does persistent occiput posterior position increase the risk of severe perineal laceration?]. ACTA ACUST UNITED AC 2011; 39:545-8. [PMID: 21873097 DOI: 10.1016/j.gyobfe.2011.07.030] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2010] [Accepted: 03/01/2011] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To assess the risk of severe perineal lacerations (III and IV degrees) during vaginal deliveries in occiput posterior position. PATIENTS AND METHODS We conducted a retrospective cohort study of 9097 vaginal deliveries in a teaching hospital's maternity between January 1st 2005 and December 31st 2008. Risk factors associated with tears of the 3rd or 4th degree were studied by a multivariate logistic regression. RESULTS Severe perineal lacerations occurred in 1.69% of cases (n=152) and did not significantly vary between 2005 and 2008. Parity was a protective factor (OR 0.42; P<0.001; IC(95%) 0.29-0.60) whereas instrumental extraction was associated with an increased risk: vacuum (OR 3.95; P<0.001, IC(95%) 2.23-7.00) and forceps (OR 3.55; P<0.001, IC(95%) 2.33-5.42). macrosomia. Risks were also increased in fetal macrosomia and episiotomy did not protect the mother (respectively OR 1.41 P<0.001, IC(95%) 1.19-1.68 and OR 1.73; P<0.001, IC(95%) 1.16-2.57). Persistent occiput posterior position was not significantly associated with an anal sphincter injury (OR=1.70 P=0.059; IC(95%) 0.98-2.94). DISCUSSION AND CONCLUSION In our series, occiput posterior position did not significantly impact the risk of severe perineal laceration. A manual rotation of the fetal head should be performed in case of associated risk factors.
Collapse
Affiliation(s)
- C Salameh
- Service de gynécologie-obstétrique, hôpital de la Croix-Rousse, hospices civils de Lyon, 103 Grande-Rue-de-la-Croix-Rousse, Lyon cedex 04, France.
| | | | | | | | | | | |
Collapse
|
14
|
Abstract
The MYST family of histone acetyltransferases (HATs) was initially defined by human genes with disease connections and by yeast genes identified for their role in epigenetic transcriptional silencing. Since then, many new MYST genes have been discovered through genetic and genomic approaches. Characterization of the complexes through which MYST proteins act, regions of the genome to which they are targeted and biological consequences when they are disrupted, all deepen the connections of MYST proteins to development, growth control and human cancers. Many of the insights into MYST family function have come from studies in model organisms. Herein, we review functions of two of the founding MYST genes, yeast SAS2 and SAS3, and the essential yeast MYST ESA1. Analysis of these genes in yeast has defined roles for MYST proteins in transcriptional activation and silencing, and chromatin-mediated boundary formation. They have further roles in DNA damage repair and nuclear integrity. The observation that MYST protein complexes share subunits with other HATs, histone deacetylases and other key nuclear proteins, many with connections to human cancers, strengthens the idea that coordinating distinct chromatin modifications is critical for regulation.
Collapse
Affiliation(s)
- A Lafon
- Section of Molecular Biology, Division of Biological Sciences, UCSD Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
| | | | | | | | | |
Collapse
|
15
|
Papin J, Armand J, Loiez V, Martin D, Dufourt I, De Pellegars C, Lafon A, Degano D, Guindo Nignan M. Choix d’indicateurs en santé au travail et mise en place d’un outil de collecte et de consolidation de ces indicateurs dans le Groupe SAFRAN. ARCH MAL PROF ENVIRO 2006. [DOI: 10.1016/s1775-8785(06)78176-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|